Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age\>18-75~* Glasgow Coma Scale (GCS) 13 or greater~* Hunt and Hess grade I, II conditions~* Admitted within 2 days of initial SAH event \>6/10 pain on presentation~Exclusion Criteria:~* Aphasia~* Head trauma within the past 30 days~* Need for craniotomy~* h/o obstructive sleep apnea or respiratory disease~* h/o opioid tolerance~* evidence of vasospasm~* h/o liver disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Control group / Standard of Care (Type: ACTIVE_COMPARATOR): * IV fentanyl bolus 25-50 mcg every 1-2 hrs as needed for pain~* (Bolus dose can be titrated up in 25 mcg increments if necessary)~* Maximum dose of 100 mcg/hr
- Low dose IV fentanyl PCA (Type: ACTIVE_COMPARATOR): * Initially: 10 mcg demand dose every 12 minutes~* No initial bolus and no continuous infusion~* Demand dose increased 10 mcg every 12 minutes if necessary~* Maximum dose of 100 mcg/hr

Based on this trial design, predict the completion outcome and termination type (if applicable).